Home › Migraine › New Jersey
Migraine clinical trials in New Jersey
9 studies for Migraine are looking for participants at sites in New Jersey.
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- JFK Neuroscience Institute, Edison
RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Nov 13, 2026 · NCT06972056Study of EVO756 in Adults With Migraine
- Bio Behavoural health, Toms River
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Nov 13, 2026 · NCT07616128A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Bio Behavioral Health, Toms River
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07816367Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- HMH Jersey Shore University Medical Center, Neptune City
- Hope Tower, Neptune City
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 27, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- HMH Jersey Shore University Medical Center, Neptune City
- HOPE Tower at Jersey Shore University Medical Center, Neptune City
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 27, 2026 · NCT04649242Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- CenExel Marlton NJ, Marlton
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Oct 9, 2026 · NCT07646613Localized Injection of Lidocaine Via the Middle Meningeal Artery for Headache Treatment
- Cooper University Health Care, Camden
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07361549The Effect of Remote Electrical Neuromodulation (REN) on Conditioned Pain Modulation (CPM) in Migraine and Fibromyalgia
- Theranica Bio-Electronics Inc, Bridgewater
Recruiting
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07841509Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Goryeb Childrens Hospital /ID# 229507, Morristown
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.